Inotuzumab ozogamicin
About
Therapy type: Targeted therapy
Therapy strategy: BCR-ABL inhibition
Mappings
NCI Thesaurus: Inotuzumab Ozogamicin (coding:ncit:C71542)
RxNorm: inotuzumab ozogamicin (coding:rxcui:1942950, coding:omop:42537249)
SNOMED: Inotuzumab ozogamicin (coding:sctid:736495009, coding:omop:794068)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (1) HSE (1) | CD22 + | Acute Lymphoid Leukemia | Inotuzumab ozogamicin | |
| EMA (2) HSE (1) | CD22 +, not BCR::ABL1 | Acute Lymphoid Leukemia | Inotuzumab ozogamicin |